These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19479657)

  • 41. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.
    Holford NH
    Clin Pharmacokinet; 1986; 11(6):483-504. PubMed ID: 3542339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic warfarin use and the extrahepatic functions of vitamin K-dependent proteins.
    Donaldson CJ; Harrington DJ
    Br J Biomed Sci; 2017 Oct; 74(4):163-169. PubMed ID: 28657840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism.
    Witt DM; Clark NP; Kaatz S; Schnurr T; Ansell JE
    J Thromb Thrombolysis; 2016 Jan; 41(1):187-205. PubMed ID: 26780746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotype-guided warfarin therapy: current status.
    Tavares LC; Marcatto LR; Santos PCJL
    Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Warfarin Pharmacogenomics in Diverse Populations.
    Kaye JB; Schultz LE; Steiner HE; Kittles RA; Cavallari LH; Karnes JH
    Pharmacotherapy; 2017 Sep; 37(9):1150-1163. PubMed ID: 28672100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Warfarin interactions with medicinal herbs.
    Milić N; Milosević N; Golocorbin Kon S; Bozić T; Abenavoli L; Borrelli F
    Nat Prod Commun; 2014 Aug; 9(8):1211-6. PubMed ID: 25233607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy.
    Leite PM; Martins MAP; Castilho RO
    Biomed Pharmacother; 2016 Oct; 83():14-21. PubMed ID: 27470545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Warfarin: pharmacological profile and drug interactions with antidepressants.
    Teles JS; Fukuda EY; Feder D
    Einstein (Sao Paulo); 2012; 10(1):110-5. PubMed ID: 23045839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-microbiota interactions: an emerging priority for precision medicine.
    Zhao Q; Chen Y; Huang W; Zhou H; Zhang W
    Signal Transduct Target Ther; 2023 Oct; 8(1):386. PubMed ID: 37806986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Special Issue: "Genomics of Stroke".
    Limborska SA; Filippenkov IB
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Licorice (
    Abraham J; Florentine S
    Plants (Basel); 2021 Nov; 10(12):. PubMed ID: 34961070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese Patients.
    Tanaka T; Ihara M; Fukuma K; Yamamoto H; Washida K; Kimura S; Kada A; Miyata S; Miyata T; Nagatsuka K
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations.
    Li D; Xie AH; Liu Z; Li D; Ning B; Thakkar S; Tong W; Xu J
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33113799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacogenetics of warfarin dosing in patients of African and European ancestry.
    Shendre A; Dillon C; Limdi NA
    Pharmacogenomics; 2018 Nov; 19(17):1357-1371. PubMed ID: 30345882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association Between Usual Vitamin K Intake and Anticoagulation in Patients Under Warfarin Therapy.
    Park JN; Lee JS; Noh MY; Sung MK
    Clin Nutr Res; 2015 Oct; 4(4):235-41. PubMed ID: 26566518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacogenetics in Jewish populations.
    Yang Y; Peter I; Scott SA
    Drug Metabol Drug Interact; 2014; 29(4):221-33. PubMed ID: 24867283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.
    Motiwala SR; Szymonifka J; Belcher A; Weiner RB; Baggish AL; Gaggin HK; Bhardwaj A; Januzzi JL
    J Cardiovasc Transl Res; 2014 Mar; 7(2):250-61. PubMed ID: 24309956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Warfarin pharmacogenetics: challenges and opportunities for clinical translation.
    Limdi NA
    Front Pharmacol; 2012; 3():183. PubMed ID: 23133417
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug induced interstitial lung disease.
    Schwaiblmair M; Behr W; Haeckel T; Märkl B; Foerg W; Berghaus T
    Open Respir Med J; 2012; 6():63-74. PubMed ID: 22896776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Personalized medicine: is it a pharmacogenetic mirage?
    Shah RR; Shah DR
    Br J Clin Pharmacol; 2012 Oct; 74(4):698-721. PubMed ID: 22591598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.